Speaker Profile
M.D., Ph.D., Chief Medical Officer, Velsera
Biography
Dr. Nagarajan has been a pioneer in genomics and informatics for 20+ years. He started at Washington University, the first CAPCLIA laboratory for clinical NGS, and where he facilitated clinical and translational research by integrating EHR, clinical trials, patient registry, biospecimen, and genomics data and by supporting complex multimodal analyses across these data types. As the Founder and President of Pierian, he built the Clinical Genomics Workspace (CGW), an endtoend disease, assay and instrument agnostic informatics solution used to process clinical NGS cases. At Velsera, Dr. Nagarajan leads the Knowledgebase team, which is responsible for curated clinical content that supports tertiary analysis in the CGW, and is responsible for regulatory submissions and for incubating and developing technology solutions to extend Velseras reach.
Talk
Analytics Insights for IVD Development and Delivery
A flexible platform is needed for analysis and interpretation of multimodal datasets, enabling biomarker discovery and characterization and subsequent IVD design. Similarly, a regulated platform is needed to support IVD development, validation, and delivery. We will present how Velseras cloud platform and services may be leveraged to achieve these goals. has context menu
Clinical Dx Showcase:
Velsera
Velsera connects healthcare and life sciences to reveal the true promise of precision medicine—a continuous flow of knowledge between researchers, scientists and clinicians around the world, creating insights that radically improve human health.
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2025 Data Applications in Clinical Diagnostics Showcase will provide a 15-30 minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Neurodegenerative
